Horus Pharma
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Jun 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 21, 2027The maintenance fee for Device for packaging and dispensing a product, with vial and dispensing mouthpiece equipped with a filter (US 11,820,546) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
- 1 fee due Oct 16, 2027The maintenance fee for Dispensing device and assembly for packaging and dispensing product (US 11,958,664) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,714,408 | Self-cleaning tip In force · From the USPTO record | In force | From the USPTO record | |
| US 9,801,899 | Artificial tear emulsion In force · From the USPTO record | In force | From the USPTO record | |
| US 10,231,990 | Preservative-Free Composition for Topical Use Including Hyaluronic Acid In force · High confidence | In force | High confidence | |
| US 10,993,835 | Device for packaging and dispensing a substance for ophthalmic use In force · From the USPTO record | In force | From the USPTO record | |
| US 10,022,266 | Device for packaging and dispensing a substance for ophthalmic use In force · From the USPTO record | In force | From the USPTO record | |
| US 11,110,116 | Hyperosmolar composition of hyaluronic acid In force · From the USPTO record | In force | From the USPTO record | |
| US 11,642,367 | Hyperosmolar composition of hyaluronic acid In force · From the USPTO record | In force | From the USPTO record | |
| US 11,235,914 | Device for packaging and dispensing a product, with vial and dispensing mouthpiece equipped with a filter In force · From the USPTO record | In force | From the USPTO record | |
| US 11,365,031 | Device for packaging and dispensing a product, having a dosing mouthpiece with an externally clean end In force · From the USPTO record | In force | From the USPTO record | |
| US 11,820,546 | Device for packaging and dispensing a product, with vial and dispensing mouthpiece equipped with a filter In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 12: 1 patent in force now held by others · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 no status recorded